Pathogenic variant. NCI Dictionary of Genetics Terms, https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/pathogenic-variant.

Bender, M. A. & Carlberg, K. Sickle cell disease. In: GeneReviews(®) (eds. Adam, M. P. et al.) (University of Washington, Seattle, 1993).

Ranque, B. et al. Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study. Lancet Haematol. 9, e208–e216 (2022).

Article  CAS  PubMed  Google Scholar 

Depetris-Chauvin, E. & Weil, D. N. Malaria and early african development: evidence from the sickle cell trait. Econ. J. (London) 128, 1207–1234 (2018).

PubMed  Google Scholar 

Gong, L., Parikh, S., Rosenthal, P. J. & Greenhouse, B. Biochemical and immunological mechanisms by which sickle cell trait protects against malaria. Malar J. 12, 317 (2013).

Article  PubMed  PubMed Central  Google Scholar 

ALLISON, A. C. Protection afforded by sickle-cell trait against subtertian malareal infection. Br. Med. J. 1, 290–294 (1954).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haldane, J. Disease and evolution. Ric. Sci. 19, 68–76 (1949).

Google Scholar 

Ashorobi, D., Ramsey, A., Yarrarapu, S. N. S. & Bhatt, R. Sickle cell trait. In StatPearls (StatPearls Publishing, 2022).

Kotila, T. R. Sickle cell trait: a benign state? Acta Haematol. 136, 147–151 (2016).

Article  CAS  PubMed  Google Scholar 

O’Connor, F. G. et al. Summit on exercise collapse associated with sickle cell trait: finding the ‘way ahead. Curr. Sports Med. Rep. 20, 47–56 (2021).

Article  PubMed  Google Scholar 

Verma, A. et al. Association of kidney comorbidities and acute kidney failure with unfavorable outcomes after covid-19 in individuals with the sickle cell trait. JAMA Intern. Med. 182, 796–804 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

MedlinePlus. HBA1 gene - hemoglobin subunit alpha 1. https://medlineplus.gov/genetics/gene/hba1/ (2022).

MedlinePlus. HBA2 gene - hemoglobin subunit alpha 2. https://medlineplus.gov/genetics/gene/hba2/ (2022).

Serjeant, G. R. et al. A plea for the newborn diagnosis of Hb S-hereditary persistence of fetal hemoglobin. Hemoglobin 41, 216–217 (2017).

Article  CAS  PubMed  Google Scholar 

Kumar, S. & Gerstein, M. Unified views on variant impact across many diseases. Trends Genet. 39, 442–450 (2023).

Castel, S. E. et al. Modified penetrance of coding variants by cis-regulatory variation contributes to disease risk. Nat. Genet. 50, 1327–1334 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hartman, J. L. 4th, Garvik, B. & Hartwell, L. Principles for the buffering of genetic variation. Science 291, 1001–1004 (2001).

Article  CAS  PubMed  Google Scholar 

Domingo, J., Baeza-Centurion, P. & Lehner, B. The causes and consequences of genetic interactions (Epistasis). Annu. Rev. Genomics Hum. Genet. 20, 433–460 (2019).

Article  CAS  PubMed  Google Scholar 

Virolainen, S. J., VonHandorf, A., Viel, K. C. M. F., Weirauch, M. T. & Kottyan, L. C. Gene-environment interactions and their impact on human health. Genes Immun. 24, 1–11 (2023).

Article  PubMed  Google Scholar 

Landrum, M. J. et al. ClinVar: improvements to accessing data. Nucleic Acids Res. 48, D835–D844 (2020).

Article  CAS  PubMed  Google Scholar 

Cooper, D. N., Krawczak, M., Polychronakos, C., Tyler-Smith, C. & Kehrer-Sawatzki, H. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum. Genet. 132, 1077–1130 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kingdom, R. & Wright, C. F. Incomplete penetrance and variable expressivity: from clinical studies to population cohorts. Front. Genet. 13, 920390 (2022).

Forrest, I. S. et al. Population-based penetrance of deleterious clinical variants. JAMA 327, 350–359 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kraft, P. Curses–winner’s and otherwise–in genetic epidemiology. Epidemiology 19, 649–651 (2008).

Article  PubMed  Google Scholar 

Ioannidis, J. P. A. Why most discovered true associations are inflated. Epidemiology 19, 640–648 (2008).

Article  PubMed  Google Scholar 

Xiang, J. et al. Reinterpretation of common pathogenic variants in ClinVar revealed a high proportion of downgrades. Sci. Rep. 10, 331 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jackson, L. et al. Influence of family history on penetrance of hereditary cancers in a population setting. eClinicalMedicine 64, 102159 (2023).

Wojcik, G. L. et al. Genetic analyses of diverse populations improves discovery for complex traits. Nature 570, 514–518 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mensah, G. A. et al. Emerging concepts in precision medicine and cardiovascular diseases in racial and ethnic minority populations. Circ. Res. 125, 7–13 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trevethan, R. Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. Front. Public Health 5, 307 (2017).

Ciesielski, T. H. et al. Diverse convergent evidence in the genetic analysis of complex disease: coordinating omic, informatic, and experimental evidence to better identify and validate risk factors. BioData Min. 7, 10 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Williams, S. M. & Haines, J. L. Correcting away the hidden heritability. Ann. Hum. Genet. 75, 348–350 (2011).

Adams, M. C., Evans, J. P., Henderson, G. E. & Berg, J. S. The promise and peril of genomic screening in the general population. Genet. Med. 18, 593–599 (2016).

Article  CAS  PubMed  Google Scholar 

Woltereck, R. Weitere experimentelle Untersuchungen uber Artveranderung, speziell uberdas Wesen quantitativer Artunterschyiede bei Daphniden. Verh. D. Tsch. Zool. Ges 1909, 110–172 (1909).

Google Scholar 

Sultan, S. E. Phenotypic plasticity as an intrinsic property of organisms. In: Phenotypic plasticity and evolution: causes, consequences, and controversies 3–24 (CRC Press).

Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Nykamp, K. et al. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet. Med. 19, 1105–1117 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Sullivan, J. A., Schoch, K., Spillmann, R. C. & Shashi, V. Exome/genome sequencing in undiagnosed syndromes. Annu. Rev. Med. 74, 489–502 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elhawary, N. A. et al. Genetic etiology and clinical challenges of phenylketonuria. Hum. Genomics 16, 22 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rothman, K. J. & Greenland, S. Causation and causal inference in epidemiology. Am. J. Public Health 95, S144–S150 (2005).

Article  PubMed  Google Scholar 

Rothman, K. J. Causes. Am. J. Epidemiol. 104, 587–592 (1976).

Article  CAS  PubMed  Google Scholar 

Gunning, A. C. et al. Assessing performance of pathogenicity predictors using clinically relevant variant datasets. J. Med. Genet. 58, 547–555 (2021).

Article  PubMed  Google Scholar 

Wilcox, E. H. et al. Evaluating the impact of in silico predictors on clinical variant classification. Genet. Med. 24, 924–930 (2022).

Article  CAS  PubMed  Google Scholar 

Pejaver, V. et al. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria. Am. J. Hum. Genet. 109, 2163–2177 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brnich, S. E. et al. Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework. Genome Med. 12, 3 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Schiabor Barrett, K. M. et al. Clinical validation of genomic functional screen data: analysis of observed BRCA1 variants in an unselected population cohort. HGG Adv. 3, 100086 (2022).

CAS  PubMed  PubMed Central  Google Scholar 

MacArthur, D. G. et al. Guidelines for investigating causality of sequence variants in human disease. Nature 508, 469–476 (2014).

Article  CAS  PubMed  PubMed Central